Skip to main content
    I

    Indaptus Therapeutics Inc (INDP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.32
    -0.13 (-3.77%)

    Market Cap: $422.38M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Indaptus Therapeutics Inc (INDP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Indaptus Therapeutics (INDP) has a market cap of $422.38M and an enterprise value of $395.77M. Its share count is up 13263.82% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 6.30% below the market cap, as cash exceeds debt.

    Market Cap$422.38M
    Enterprise Value$395.77M
    Latest price (Nov 17, 2026)$3.32

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 14.73% in the quarter ended Sep 30, 2026 and grew 1880.61% a year over 2 years.

    Shares Outstanding133.24M
    Shares Change (YoY)+13263.82%
    Shares Change (QoQ)+14.73%
    Share Count Growth (2Y CAGR)+1880.61%

    Price Statistics

    The stock is up 32.27% over 52 weeks and trades 9.57% above its 50-day average.

    Beta (1Y)1.59
    52-Week Change+32.27%
    1-Month Change+21.61%
    3-Month Change+253.19%
    6-Month Change+149.62%
    5-Year Change-98.46%
    10-Year Change-99.97%
    Total Return (1Y)+32.27%
    Total Return (3Y CAGR)-61.38%
    Total Return (5Y CAGR)-53.75%
    Return vs SPY (1Y)+32.16%
    Max Drawdown (1Y)-80.29%
    Max Drawdown (3Y)-98.81%
    Sharpe Ratio (1Y)0.20
    Correlation with SPY (1Y)0.12
    50-Day Average$3.03
    200-Day Average$2.33
    52-Week Range$0.92 to $5.96
    RSI (14 Days)54.8
    Average Volume (20 Days)251.61K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 94.60x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio94.60x
    Quick Ratio94.60x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -130.63% and return on assets is -43.24% over the last 12 months.

    Return on Equity (ROE)-130.63%
    Return on Assets (ROA)-43.24%
    Return on Capital Employed (ROCE)-44.30%

    Scores

    INDP has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$13.26M
    Pretax Income-$13.68M
    Net Income-$13.50M
    EBIT-$13.68M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.10% of the $31.21M in total assets.

    Cash and Equivalents$26.60M
    Total Debt$0
    Net Cash$26.60M
    Net Cash Per Share$0.20
    Working Capital$30.88M
    Shareholder Equity$10.33M
    Book Value Per Share$0.08
    Total Assets$31.21M
    Total Liabilities$20.88M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$13.56M
    FCF Per Share-$0.10
    Share Repurchases$207.91K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+0.42%
    Tangible Book Per Share Growth (2Y CAGR)+0.42%

    Revenue and profit by year

    Dividends and Yields

    INDP does not pay a dividend.

    Buyback Yield-2.67%
    Shareholder Yield-2.67%

    Stock Splits

    The last split was a 1-for-28 reverse split on Jun 27, 2025.

    Last Split DateJun 27, 2025
    Split TypeReverse split
    Split Ratio1:28

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About INDP

    What is INDP's market cap?

    Indaptus Therapeutics has a market cap of $422.38M. Its enterprise value, which adds debt and subtracts cash, is $395.77M.

    How many shares of INDP are outstanding?

    Indaptus Therapeutics has 133.24M shares outstanding. The count is up 13263.82% from a year earlier.

    Does INDP pay a dividend?

    No. Indaptus Therapeutics does not pay a dividend.

    How much debt does INDP have?

    Indaptus Therapeutics has $0 of total debt and $26.60M of cash and equivalents, a net cash position of $26.60M.